NZ601871A - Compositions and methods for the treatment of diseases and disorders associated with cytokine signaling involving antibodies that bind to il-22 and il-22r - Google Patents
Compositions and methods for the treatment of diseases and disorders associated with cytokine signaling involving antibodies that bind to il-22 and il-22rInfo
- Publication number
- NZ601871A NZ601871A NZ601871A NZ60187106A NZ601871A NZ 601871 A NZ601871 A NZ 601871A NZ 601871 A NZ601871 A NZ 601871A NZ 60187106 A NZ60187106 A NZ 60187106A NZ 601871 A NZ601871 A NZ 601871A
- Authority
- NZ
- New Zealand
- Prior art keywords
- antibody
- bind
- diseases
- compositions
- treatment
- Prior art date
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ621483A NZ621483A (en) | 2005-12-02 | 2006-11-30 | Compositions and methods for the treatment of diseases and disorders associated with cytokine signaling involving antibodies that bind to il-22 and il-22r |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US74164005P | 2005-12-02 | 2005-12-02 | |
US82259706P | 2006-08-16 | 2006-08-16 | |
NZ56877706 | 2006-11-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ601871A true NZ601871A (en) | 2014-10-31 |
Family
ID=51796516
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ601871A NZ601871A (en) | 2005-12-02 | 2006-11-30 | Compositions and methods for the treatment of diseases and disorders associated with cytokine signaling involving antibodies that bind to il-22 and il-22r |
Country Status (1)
Country | Link |
---|---|
NZ (1) | NZ601871A (en) |
-
2006
- 2006-11-30 NZ NZ601871A patent/NZ601871A/en not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ621483A (en) | Compositions and methods for the treatment of diseases and disorders associated with cytokine signaling involving antibodies that bind to il-22 and il-22r | |
SG153878A1 (en) | Chimeric and humanised monoclonal antibodies against inteleukin-13 | |
RU2474588C2 (en) | Cross-reactive antibodies anti-il-17a/il-17f and methods for use thereof | |
NZ597023A (en) | Monoclonal antibodies that bind to hGM-CSF and medical compositions comprising same | |
MX2022003249A (en) | Anti-tnfr2 antibodies and methods of use. | |
WO2005110474A3 (en) | HUMANIZED FcϜRIIB SPECIFIC ANTIBODIES AND METHODS OF USE THEREOF | |
UA94060C2 (en) | Monoclonal antibodies that specifically binds alk-1 | |
RS53157B (en) | Anti-sclerostin antibodies | |
WO2005115452A3 (en) | Fcϝriib-specific antibodies and methods of use thereof | |
MY145042A (en) | Humanized monoclonal antibodies to hepatocyte growth factor | |
NZ595235A (en) | Compositions and methods for increasing muscle growth | |
NZ616992A (en) | Anti-ilt7 antibody | |
CY1115456T1 (en) | METHOD OF ADJUSTMENT OF ANTI-ANTI-IL-5 | |
WO2009140348A4 (en) | Anti-il-6/il-6r antibodies and methods of use thereof | |
MY153893A (en) | Antibodies against human il17 and uses thereof | |
MY149630A (en) | Antibodies against amyloid-beta peptide | |
HRP20221471T1 (en) | Anti-fgfr3 antibodies and methods using same | |
HRP20100521T1 (en) | Monoclonal antibodies to hepatocyte growth factor | |
TW200738748A (en) | Human monoclonal antibody human CD134 (OX40) and methods of making and using same | |
WO2008105886A3 (en) | HUMANIZED FCγRIIB-SPECIFIC ANTIBODIES AND METHODS OF USE THEREOF | |
TW200736274A (en) | Immunoglobulins | |
UA92504C2 (en) | Anti-myostatin monoclonal antibody | |
GEP20125471B (en) | Compositions monovalent for cd40l binding and methods of use | |
UA95478C2 (en) | Humanized c-kit antibody | |
MX2009001110A (en) | Anti-il-6 monoclonal antibodies and uses thereof. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ERR | Error or correction |
Free format text: THE MISSING INVENTOR HAS BEEN ADDED (1209144, SA, SUSAN; 1209147, WU, JIANFENG; 1328986, DANILENKO, DIMITRY, M.; 1328991, VALDEZ, PATRICIA, A.; 1328992, ZHENG, YAN; 1339084, CHEN, YVONNE; 3098195, CHUNTHARAPAI, ANAN, 826 ELLIS DRIVE, COLMA, CALIFORNIA 94015, US; 3098199, WONG, TERENCE, 312 SHELL GATE ROAD, ALAMEDA, CALIFORNIA 94501, US; 3107002, OUYANG, WENJUN, 1057 GALLEY LANE, FOSTER CITY, CALIFORNIA 94404, US) Effective date: 20140127 |
|
ERR | Error or correction |
Free format text: THE INVENTOR HAS BEEN CORRECTED TO 1209142, DANILENKO, DIMITRY; 1209144, SA, SUSAN; 1209145, VALDEZ, PATRICIA; 1209147, WU, JIANFENG; 1328992, ZHENG, YAN; 1339084, CHEN, YVONNE; 3098195, CHUNTHARAPAI, ANAN, 826 ELLIS DRIVE, COLMA, CALIFORNIA 94015, US; 3098199, WONG, TERENCE, 312 SHELL GATE ROAD, ALAMEDA, CALIFORNIA 94501, US; 3107002, OUYANG, WENJUN, 1057 GALLEY LANE, FOSTER CITY, CALIFORNIA 94404, US Effective date: 20141010 |
|
PSEA | Patent sealed | ||
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 6 YEARS UNTIL 30 NOV 2016 BY AJ PARK Effective date: 20150311 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 30 NOV 2017 BY THOMSON REUTERS Effective date: 20161022 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 30 NOV 2018 BY THOMSON REUTERS Effective date: 20171012 |
|
LAPS | Patent lapsed |